Font Size:
a
A
A
Keyword [Human immunodeficiency virus type-1]
Result: 81 - 94 | Page: 5 of 5
81.
Do nucleoside analog-resistance mutations increase the fidelity of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase
82.
Biochemical and pharmacological characterizations of the structure and function of human immunodeficiency virus type 1 integrase and its role during early steps of the viral life cycle
83.
Isolation of two highly potent and non-toxic inhibitors of human immunodeficiency virus type 1 (HIV-1) integrase and viral replication
84.
Immunopathogenesis of human immunodeficiency virus type-1 (HIV-1) in the gastrointestinal mucosal compartment
85.
The role of lipid rafts in the biology of the human immunodeficiency virus type 1
86.
Human immunodeficiency virus type 1 subtype C: Molecular characterization and development of an animal model
87.
The effects of nonnucleoside reverse transcriptase inhibitor resistance mutations on human immunodeficiency virus type 1 replication and reverse transcriptase function
88.
Entry mechanisms and pathologic effects mediated by the envelope glycoproteins of the human immunodeficiency virus type 1, Marburg, and Ebola viruses
89.
VPU-binding protein (UBP) and its role in human immunodeficiency virus type 1 (HIV-1) particle release
90.
Proviral latency, transcriptional activation, and CD4 downregulation during human immunodeficiency virus type 1 infection
91.
The effects of insulin and insulin-like growth factor-I on the replication of the human immunodeficiency virus type 1 in vitro
92.
Molecular characterization of retroviral mediated immunosuppression: Human immunodeficiency virus type 1 as a prototype
93.
Transcriptional regulation of human immunodeficiency virus type 1 via the cis-acting binding elements in the long terminal repeat
94.
Molecular Epidemiology of Human Immunodeficiency Virus Type 1 (HIV-1) in Southern Africa and Northern Californi
<<First
<Prev
Next>
Last>>
Jump to